In addition, PFKFB3 is commonly overexpressed in breast, colon, ovarian, and thyroid cancers but is expressed at low levels in normal tissues and is the basis of targeted therapy for a variety of cancers [166]. The gene discussed is PFKFB3; the disease is cancer.